Global ECMO Devices Market Growth 2023-2029

Global ECMO Devices Market Growth 2023-2029

Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.
LPI (LP Information)' newest research report, the “ECMO Devices Industry Forecast” looks at past sales and reviews total world ECMO Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected ECMO Devices sales for 2023 through 2029. With ECMO Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ECMO Devices industry.
This Insight Report provides a comprehensive analysis of the global ECMO Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on ECMO Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global ECMO Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ECMO Devices and breaks down the forecast by type, by end users, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ECMO Devices.
The global ECMO Devices market size is projected to grow from US$ 231.7 million in 2022 to US$ 301.7 million in 2029; it is expected to grow at a CAGR of 301.7 from 2023 to 2029.
Global players of ECMO Devices include Medtronic, Getinge (Maquet), LivaNova (Sorin), Terumo and Fresenius Medical Care. Medtronic is the largest player, with a share about 34%. North America is the largest market, with a share about 40%, followed by Europe and China. In terms of product, VV (Veno-Venous) ECMO is the largest segment, with a share over 70%. In terms of application, Adult is the largest market, with a share about 80%.
This report presents a comprehensive overview, market shares, and growth opportunities of ECMO Devices market by product type, end users, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
VA (Veno-Arterial) ECMO
VV (Veno-Venous) ECMO
Segmentation by end users
Adult
Neonatal
Pediatric
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Getinge (Maquet)
LivaNova (Sorin)
Terumo
Fresenius Medical Care
Key Questions Addressed in this Report
What is the 10-year outlook for the global ECMO Devices market?
What factors are driving ECMO Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do ECMO Devices market opportunities vary by end market size?
How does ECMO Devices break out type, end users?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.